United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - diphenhydramine hydrochloride - oral tablet - 25mg

United Kingdom - Inggeris - MHRA (Medicines & Healthcare Products Regulatory Agency)

ennogen healthcare ltd - diphenhydramine hydrochloride - oral tablet - 50mg

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

advance pharmaceutical inc. - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 50 mg - sleep aid  relieves occasional sleeplessness

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

richmond pharmaceuticals, inc. - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 50 mg - antihistamine temporarily relieves these symptoms of hay fever or other upper respiratory allergies: - runny nose - itchy nose or throat - sneezing - itchy, watery eyes

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

epic pharma, llc - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 25 mg - antihistamine temporarily relieves these symptoms of hay fever or other upper respiratory allergies: - runny nose - sneezing - itchy nose or throat - itchy, watery eyes

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

lake erie medical dba quality care products llc - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride 25 mg

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

dispensing solutions, inc. - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride injection is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when the oral form is impractical: for amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. for active treatment of motion sickness. for use in parkinsonism, when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents, mild cases of parkinsonism in other age groups and in other ca

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

rebel distributors corp - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride injection is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when the oral form is impractical: for amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. for active treatment of motion sickness. for use in parkinsonism, when oral therapy is impossible or contraindicated, as follows: parkinsonism in the elderly who are unable to tolerate more potent agents, mild cases of parkinsonism in other age groups and in other cases of parkinsonism in combination with centrally acting anticholinergic agents. this drug should not be used in neonates or premature infants. because of the higher risk of antihistamines for infants generally, and for neonates and prematures in particular, ant

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

general injectables & vaccines, inc - diphenhydramine hydrochloride (unii: tc2d6jad40) (diphenhydramine - unii:8gts82s83m) - diphenhydramine hydrochloride injection is effective in adults and pediatric patients, other than premature infants and neonates, for the following conditions when the oral form is impractical: antihistaminic- for amelioration of allergic reactions to blood or plasma, in anaphylaxis as an adjunct to epinephrine and other standard measures after the acute symptoms have been controlled and for other uncomplicated allergic conditions of the immediate type when oral therapy is impossible or contraindicated. motion sickness- for active treatment of motion sickness. antiparkinsonism- for use in parkinsonism, when oral therapy is impossible or contraindicated, as follows:  parkinsonism in the elderly who are unable to tolerate more potent agents, mild cases at parkinsonism in other age groups and in other cases of parkinsonism in combination with centrally acting anticholinergic agents. use in neonates or premature infants this drug should not be used in neonates or premature infants. use in nursing mothers becaus

Amerika Syarikat - Inggeris - NLM (National Library of Medicine)

nucare pharmaceuticals, inc. - diphenoxylate hydrochloride (unii: w24od7yw48) (diphenoxylate - unii:73312p173g), atropine sulfate (unii: 03j5ze7ka5) (atropine - unii:7c0697dr9i) - diphenoxylate hydrochloride and atropine sulfate tablets, usp are effective as adjunctive therapy in the management of diarrhea. diphenoxylate hydrochloride and atropine sulfate tablets are contraindicated in patients with - known hypersensitivity to diphenoxylate or atropine, - obstructive jaundice, - diarrhea associated with pseudomembranous enterocolitis or enterotoxin-producing bacteria. diphenoxylate hydrochloride and atropine sulfate tablets are classified as a schedule v controlled substance. diphenoxylate hydrochloride is chemically related to the narcotic analgesic meperidine. in doses used for the treatment of diarrhea, whether acute or chronic, diphenoxylate has not produced addiction. diphenoxylate hydrochloride is devoid of morphine-like subjective effects at therapeutic doses. at high doses it exhibits codeine-like subjective effects. the dose which produces antidiarrheal action is widely separated from the dose which causes central nervous system effects. the insolubility of diphenoxylate hydro